MRC Molecular Haematology Unit
We aim to understand how mature blood cells are normally made from stem cells and how this is perturbed in common blood disorders. Ultimately, our purpose is to improve the prognosis of patients with inherited and acquired blood diseases.
Unit Director
Patient involvement partnership sets priorities for rare anaemias
Patients, carers, clinicians and researchers collaborate to decide key research questions for future research.
Read moreNew technique to analyse cancer cells' life history
Analysing tumours cell by cell will help develop personalised cancer treatments.
Read moreMRC WIMM research at the Royal Institution
How can genome editing improve human health? That's the theme our researchers took to the latest Royal Institution Family Fun Day in London!
Read moreClinical Academic Research Partnership to improve diagnosis of MDS
Many congratulations to Dr Onima Chowdhury, awarded a £250,000 grant by the Medical Research Council
Read moreLatest Publications
-
Cell-Intrinsic Depletion of AML1-ETO-Positive Pre-Leukemic HSCs By Kras Activating Mutation
Di Genua C. et al, (2017), BLOOD, 130
-
Etv6 activates vegfa expression through positive and negative transcriptional regulatory networks in Xenopus embryos.
Li L. et al, (2019), Nat Commun, 10
-
Unravelling Intratumoral Heterogeneity through High-Sensitivity Single-Cell Mutational Analysis and Parallel RNA Sequencing.
Rodriguez-Meira A. et al, (2019), Mol Cell
-
Structure-based development of new RAS-effector inhibitors from a combination of active and inactive RAS-binding compounds.
Cruz-Migoni A. et al, (2019), Proc Natl Acad Sci U S A
-
SCL/TAL1 cooperates with Polycomb RYBP-PRC1 to suppress alternative lineages in blood-fated cells.
Chagraoui H. et al, (2018), Nat Commun, 9
Latest News
WIMM day 2019 a success
1 April 2019
MRC WIMM researchers excel at RDM day
15 March 2019
Patient involvement partnership sets priorities for rare anaemias
28 February 2019